North Carolina is the latest state considering a ban on smokable hemp, a product that’s exploding along with the health craze surrounding a compound in the plant known as CBD.
Besides federal regulations laid out in the Hemp Farming Act of 2018, the Food and Drug Administration has no additional regulations on smokable hemp, leaving states to figure out how to govern it themselves.
This year, Indiana, Louisiana and Texas banned smokable hemp entirely, while Kansas banned products including hemp cigarettes and cigars. Tennessee prohibited smokable hemp sales to minors. Continue reading “North Carolina Proposes Smokable Hemp Ban as Demand Grows”
U.K. company GW Pharmaceuticals has revealed how much their new epilepsy drug Epidiolex will cost. Epidiolex was approved for use in the U.S. by the Food and Drug Administration in June. The drug is the first medication derived from cannabis to receive approval from the agency. Continue reading “Pharmaceutical Company Reveals Cost of FDA-Approved Cannabis Based Medicine”
Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial Continue reading “What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals”
In 2009, Alfred Caronia, then a sales representative for a pharmaceutical company working in New York City and on Long Island, was convicted of federal charges for telling doctors tall tales about the drug he was selling.
Caronia worked for a company called Orphan Medical, the manufacturer and marketer of a drug called Xyrem. Xyrem is a powerful central nervous system depressant that’s approved by the FDA for use in treating narcolepsy. Continue reading “Under Donald Trump, It’s Boom Times for Drug Fraudsters”
Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug. Continue reading “Anti-Legalization Big Pharma Company Has Their Synthetic THC Drug Approved By FDA”
A conservative doctor-turned-pundit with deep ties to Wall Street and the pharmaceutical industry is President Donald Trump’s pick to lead the Food and Drug Administration.
Dr. Scott Gottlieb would be tasked with Trump’s goal of cutting red tape at the FDA, which regulates everything from pharmaceuticals to seafood to electronic cigarettes. Continue reading “Trump’s Choice for FDA Has Ties to Wall Street, Drug Makers”